BEYOND STATINS Trademark

Trademark Overview

On Friday, June 15, 2012, a trademark application was filed for BEYOND STATINS with the United States Patent and Trademark Office. The USPTO has given the BEYOND STATINS trademark a serial number of 85653300. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 5, 2020. This trademark is owned by Esperion Therapeutics, Inc.. The BEYOND STATINS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular and metabolic diseases
beyond statins

General Information

Serial Number85653300
Word MarkBEYOND STATINS
Filing DateFriday, June 15, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 5, 2020
Registration Number4422739
Registration DateTuesday, October 22, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2012

Trademark Statements

Disclaimer with Predetermined Text"STATINS"
Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular and metabolic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 5, 2020
Primary Code005
First Use Anywhere DateSunday, June 30, 2013
First Use In Commerce DateSunday, June 30, 2013

Trademark Owner History

Party NameEsperion Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPlymouth, MI 48170
Party NameEsperion Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPlymouth, MI 48170
Party NameEsperion Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPlymouth, MI 48170

Trademark Events

Event DateEvent Description
Friday, June 5, 2020CANCELLED SEC. 8 (6-YR)
Monday, October 22, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, November 11, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 11, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 22, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, September 17, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, September 16, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, September 7, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 6, 2013STATEMENT OF USE PROCESSING COMPLETE
Monday, August 5, 2013USE AMENDMENT FILED
Friday, August 30, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 5, 2013TEAS STATEMENT OF USE RECEIVED
Friday, July 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 3, 2013EXTENSION 1 GRANTED
Wednesday, July 3, 2013EXTENSION 1 FILED
Wednesday, July 3, 2013TEAS EXTENSION RECEIVED
Tuesday, January 8, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 13, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 9, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 9, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 5, 2012EXAMINER'S AMENDMENT ENTERED
Friday, October 5, 2012ASSIGNED TO LIE
Friday, October 5, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 5, 2012EXAMINERS AMENDMENT E-MAILED
Friday, October 5, 2012EXAMINERS AMENDMENT -WRITTEN
Friday, September 28, 2012ASSIGNED TO EXAMINER
Monday, June 25, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 19, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

statins beyond metabolic diseases cardiovascular treatment preparations pharmaceutical